Correlation Between Champions Oncology and Recursion Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Champions Oncology and Recursion Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Champions Oncology and Recursion Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Champions Oncology and Recursion Pharmaceuticals, you can compare the effects of market volatilities on Champions Oncology and Recursion Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Champions Oncology with a short position of Recursion Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Champions Oncology and Recursion Pharmaceuticals.
Diversification Opportunities for Champions Oncology and Recursion Pharmaceuticals
0.16 | Correlation Coefficient |
Average diversification
The 3 months correlation between Champions and Recursion is 0.16. Overlapping area represents the amount of risk that can be diversified away by holding Champions Oncology and Recursion Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Recursion Pharmaceuticals and Champions Oncology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Champions Oncology are associated (or correlated) with Recursion Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Recursion Pharmaceuticals has no effect on the direction of Champions Oncology i.e., Champions Oncology and Recursion Pharmaceuticals go up and down completely randomly.
Pair Corralation between Champions Oncology and Recursion Pharmaceuticals
Given the investment horizon of 90 days Champions Oncology is expected to generate 0.69 times more return on investment than Recursion Pharmaceuticals. However, Champions Oncology is 1.45 times less risky than Recursion Pharmaceuticals. It trades about 0.21 of its potential returns per unit of risk. Recursion Pharmaceuticals is currently generating about 0.13 per unit of risk. If you would invest 391.00 in Champions Oncology on September 1, 2024 and sell it today you would earn a total of 61.00 from holding Champions Oncology or generate 15.6% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Champions Oncology vs. Recursion Pharmaceuticals
Performance |
| Timeline |
| Champions Oncology |
| Recursion Pharmaceuticals |
Champions Oncology and Recursion Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Champions Oncology and Recursion Pharmaceuticals
The main advantage of trading using opposite Champions Oncology and Recursion Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Champions Oncology position performs unexpectedly, Recursion Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Recursion Pharmaceuticals will offset losses from the drop in Recursion Pharmaceuticals' long position.| Champions Oncology vs. Molecular Partners AG | Champions Oncology vs. MediciNova | Champions Oncology vs. Anebulo Pharmaceuticals | Champions Oncology vs. Shattuck Labs |
| Recursion Pharmaceuticals vs. Absci Corp | Recursion Pharmaceuticals vs. Affimed NV | Recursion Pharmaceuticals vs. Sana Biotechnology | Recursion Pharmaceuticals vs. Relay Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..
Other Complementary Tools
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |